CATHERINE FRANCIN: Open Payments
NPI 1073880324 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 24 payments from 8 companies in 2025. Trend: 2023 $377 · 2024 $667 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $703 |
| Janssen Biotech, Inc. | 4 | $340 |
| Gilead Sciences, Inc. | 1 | $130 |
| Madrigal Pharmaceuticals | 1 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Lilly USA, LLC | 1 | $32 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, RINVOQ, CREON, Livdelzi, SKYRIZI, LINZESS, MAVYRET, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
